NICE Guidance - March 2020
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of March 2020. This month there are three guidelines that impact upon primary care. There are also three rapid guideline and evidence reviews related to COVID-19.
The Tinnitus: assessment and management guideline has been published. It covers the assessment, investigation and management of tinnitus in primary, community and secondary care. It offers advice to healthcare professionals on supporting people presenting with tinnitus and on when to refer for specialist assessment and management.
The Abdominal aortic aneurysm: diagnosis and management guideline has been published. It covers diagnosing and managing abdominal aortic aneurysms. It aims to improve care by helping people who are at risk to get tested, specifying how often to monitor asymptomatic aneurysms, and identifying when aneurysm repair is needed and which procedure will work best.
The Venous thromboembolic diseases: diagnosis, management and thrombophilia testing guideline has been published. It covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, such as thrombophilia (a blood clotting disorder) and cancer.
The COVID-19 rapid guideline: critical care guideline has been published. It aims to maximise the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.
The COVID-19 rapid guideline: dialysis service delivery guideline has been published. It aims to maximise the safety of patients on dialysis, while protecting staff from infection. It will also enable dialysis services to make the best use of NHS resources and match the capacity of dialysis services to patient needs if these become limited because of the COVID-19 pandemic.
The COVID-19 rapid guideline: delivery of systemic anticancer treatments guideline has been published. It aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandemic.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Drug Safety Update - March 2020 | CKS Updates - March 2020 » |
Leave a Comment